Infliximab 20 mg/kg

( DrugBank: Infliximab / KEGG DRUG: Infliximab )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
96	クローン病	17

96. クローン病

臨床試験数 : 2,442 / 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209

trials per page:

Showing 1 to 10 of 17 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2019-003068-39-NL (EUCTR)	20/11/2019	04/11/2019	In patients with inflammatory bowel disease (IBD) on infliximab(IFX) maintenance treatment, low trou ...	Withdrawal of Infliximabin patients with inflammatory bowel disease in remission guided by pharmacok ...	Inflammatory Bowel Disease (IBD) Ulcerative colitis Crohn's disease;Therapeutic area: Diseases [C] - ...	Trade Name: Infliximab Product Name: Infliximab INN or Proposed INN: INFLIXIMAB	UMC Utrecht	NULL	Not Recruiting			Female: yes Male: yes	30	Phase 4	Netherlands
2	EUCTR2018-002925-47-ES (EUCTR)	28/12/2018	16/11/2018	prediction of response to therapy in inflammatory bowel disease	Identification of predictive biomarkers for response to biologic therapies in inflammatory bowel dis ...	Inflammatory bowel disease MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcera ...	Trade Name: Adalimumab INN or Proposed INN: ADALIMUMAB Trade Name: Infliximab INN or Proposed INN: INFL ...	Fundación de Investigación Biomédica del Hospital Universitario de La Princesa	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	180	Phase 4	Spain
3	EUCTR2015-004618-10-BE (EUCTR)	19/04/2016	20/11/2015	PhArmaCo-kinetics of InFliximab during treatment Induction	Study of the inter-individual variation of PhArmaCo-kinetics of InFliximabduring treatment Induction ...	Patients with Crohn disease or Ulcerative Colitis which need biotherapy (antibody against TNF-a);The ...	Trade Name: Remsima INN or Proposed INN: INFLIXIMAB Other descriptive name: Remsima Trade Name: Remicad ...	CUB- Hopital Erasme	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes		Phase 4	Belgium
4	EUCTR2012-002702-51-NO (EUCTR)	07/03/2016	03/02/2016	Discontinuation of biologic therapy (infliximab) in patients with Crohn’s disease during sustained c ...	Discontinuation of infliximabtherapy in patients with Crohn’s disease during sustained complete remi ...	Patients with Crohn's disease with absence of disease activity during biologic therapy (infliximab) ...	Trade Name: Remicade Product Name: Remicade INN or Proposed INN: INFLIXIMAB Trade Name: Remsima Product ...	Department of medical gastroenterology, Herlev Hospital	NULL	Not Recruiting			Female: yes Male: yes	136	Phase 4	Finland;Denmark;Norway;Sweden
5	EUCTR2012-002702-51-FI (EUCTR)	12/10/2015	30/09/2015	Discontinuation of biologic therapy (infliximab) in patients with Crohn’s disease during sustained c ...	Discontinuation of infliximabtherapy in patients with Crohn’s disease during sustained complete remi ...	Patients with Crohn's disease with absence of disease activity during biologic therapy (infliximab) ...	Trade Name: Remicade Product Name: Remicade INN or Proposed INN: INFLIXIMAB Trade Name: Remsima Product ...	Department of medical gastroenterology, Herlev Hospital	NULL	Not Recruiting			Female: yes Male: yes	5	Phase 4	Finland;Denmark;Norway;Sweden
6	EUCTR2012-002702-51-SE (EUCTR)	10/08/2015	10/06/2015	Discontinuation of biologic therapy (infliximab) in patients with Crohn’s disease during sustained c ...	Discontinuation of infliximabtherapy in patients with Crohn’s disease during sustained complete remi ...	Patients with Crohn's disease with absence of disease activity during biologic therapy (infliximab) ...	Trade Name: Remicade Product Name: Remicade INN or Proposed INN: INFLIXIMAB Trade Name: Remsima Product ...	Department of medical gastroenterology S, Odense University Hospital	NULL	Not Recruiting			Female: yes Male: yes	136	Phase 4	Finland;Denmark;Norway;Sweden
7	EUCTR2012-002702-51-DK (EUCTR)	24/09/2012	01/08/2012	Discontinuation of biologic therapy (infliximab) in patients with Crohn’s disease during sustained c ...	Discontinuation of infliximabtherapy in patients with Crohn’s disease during sustained complete remi ...	Patients with Crohn's disease with absence of disease activity during biologic therapy (infliximab) ...	Trade Name: Remicade Product Name: Remicade INN or Proposed INN: INFLIXIMAB Trade Name: Remsima Product ...	Department of medical gastroenterology S, Odense University Hospital	NULL	Not Recruiting			Female: yes Male: yes	136	Phase 4	Finland;Denmark;Norway;Sweden
8	NCT01181765 (ClinicalTrials.gov)	June 2012	12/8/2010	The Efficacy of Open Label Infliximabfor the Induction and Maintenance of Mucosal Healing in Small B ...	The Efficacy of Open Label Infliximabfor the Induction and Maintenance of Mucosal Healing in Small B ...	Crohn's Disease	Biological: Infliximab 5 mg/kg body weight infused over 2 hours	Janssen Inc.	NULL	Completed	18 Years	N/A	Both	1	Phase 4	Canada
9	EUCTR2008-005688-32-CZ (EUCTR)	02/07/2009	05/01/2009	Biological therapy in the prevention of Crohn`s disease recurrence after resection in ileocecal regi ...	Biological therapy in the prevention of Crohn`s disease recurrence after resection in ileocecal regi ...	Prevention of Crohn`s disease recurrence after surgery in ileocecal region by postoperative applicat ...	Trade Name: Remicade INN or Proposed INN: INFLIXIMAB	Univeristy Hospital Na Bulovce	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	50	Phase 3	Czech Republic
10	EUCTR2006-004784-58-GB (EUCTR)	03/06/2009	30/04/2009	An Open Label, Prospective, Multi-Center Trial on the Effect of Anti-TNF Chimeric Monoclonal Antibod ...	An Open Label, Prospective, Multi-Center Trial on the Effect of Anti-TNF Chimeric Monoclonal Antibod ...	Crohn's disease MedDRA version: 8.1;Level: LLT;Classification code 10011401;Term: Crohn's disease	Trade Name: Remicade Product Name: Remicade INN or Proposed INN: Infliximab	University of Leuven Hospitals	NULL	Not Recruiting			Female: yes Male: yes	25	Phase 4	France;Belgium;Germany;United Kingdom

First Previous1 2Next Last